Poging GOUD - Vrij

Time to Beat Apple

Forbes Middle East - English

|

July 2025 English

Small value stocks haven't been doing well. But money manager MILES LEWIS makes the case that at a time of turbulence on Wall Street, they are ready for a rebound.

- By William Baldwin

Time to Beat Apple

Tariffs. Inflation. Economic chaos.

Bring it on, says Miles Lewis, manager of a portfolio of quirky stocks that, he says, are better equipped than the average stock to weather a tumultuous time in the U.S. economy.

Recession? That should send shoppers for sporting goods out of high-class vendors to the downmarket chain he favors. Rising interest rates? A steeper yield curve would benefit the venerable savings bank in which Lewis has a stake. Economic uncertainty? That will make it hard for municipalities to sell bonds, so they will be patronizing a bond insurer he likes.

Lewis runs $1.5 billion, most of it in the Royce Small-Cap Total Return Fund. A story goes with each of the fund’s 60 stocks, but there’s also a big-picture bullish case. Small companies are more domestically oriented than the multinationals in the S&P 500. “They're more insulated from retaliatory tariffs and deglobalization,” Lewis says.

Another tailwind might come from the fact that stocks like the ones Lewis holds are overdue for a rebound. In the 16 years since the financial crisis, Wall Street’s winners have been big growth companies. The money management firm created 53 years ago by Charles Royce is in the opposite corner of the market.

The companies in Small-Cap Total Return average a market value a thousandfold smaller than that of Apple. They are cheap, too, trading at a collective 13 times trailing earnings, to 21 for the S&P (both calculations omit companies losing money). It would be better for Lewis if his stocks weren't quite so cheap. Like most of what's in the Royce lineup, his fund can, net of its 1.2% annual fee, boast of benchmark-beating returns since inception (for this fund, in 1993). But that’s not good enough. When investors compare the results not to an index of small value stocks but to the S&P 500 they feel they are missing out.

MEER VERHALEN VAN Forbes Middle East - English

Forbes Middle East - English

Forbes Middle East - English

The 10 Richest Women In America 2025

For the first time in six years, the number of women on The Forbes 400 list has slipped.

time to read

2 mins

October 2025 ENGLISH

Forbes Middle East - English

Forbes Middle East - English

A DIVERSIFIED INTENTION

Sara Masmoudi, CEO of Kilani Group, has led one of Tunisia's most dynamic growth stories through a strategy anchored in acquisitions, partnerships, and diversification, while keeping healthcare and pharmaceuticals at its heart. Today, she is continuing the group's legacy into its next chapter with bold ambitions to expand deeper into Africa and the Middle East.

time to read

7 mins

October 2025 ENGLISH

Forbes Middle East - English

TOP HEALTHCARE LEADERS 2025

The Middle East healthcare industry continues to advance in its new era of transformation and integration, driven by digital health, local manufacturing, cross-border collaborations and the rapid rise of AI and robotics.

time to read

9 mins

October 2025 ENGLISH

Forbes Middle East - English

Forbes Middle East - English

Medical Breakthroughs of 2025

From novel treatments of lipid storage diseases, acute pain, and Hemophilia, to marketing authorizations of tests for the diagnosis of several conditions, here are some of the key medical breakthroughs of 2025, so far.

time to read

3 mins

October 2025 ENGLISH

Forbes Middle East - English

Forbes Middle East - English

Healthcare M&A Deals Driving Growth Across MENA in 2025

Healthcare M&A in the Middle East remained steady in H1 2025, with 20 deals, compared to 19 in the same period last year, according to PwC's 2025 TransAct Middle East Mid-Year Update. Here are some notable deals secured in 2025, so far.

time to read

2 mins

October 2025 ENGLISH

Forbes Middle East - English

Forbes Middle East - English

PEOPLE ON TOP

Under John Sunil's leadership, Burjeel Holdings has become a $1.9 billion healthcare powerhouse, treating millions and pioneering specialties from oncology to transplants. Now, the CEO is steering its next phase of growth with Saudi expansion, Al investments, and a bold push into new markets.

time to read

7 mins

October 2025 ENGLISH

Forbes Middle East - English

Forbes Middle East - English

TOP HEALTHCARE LEADERS 2025 - EXECUTIVES

Al Huqbani was appointed CEO of Health Holding Company in January 2023, following the Saudi Cabinet's decision in 2022 to transfer healthcare assets from the Ministry of Health to HHC and its subsidiaries, making it the largest health provider in Saudi Arabia.

time to read

4 mins

October 2025 ENGLISH

Forbes Middle East - English

Forbes Middle East - English

The 10 Youngest Billionaires On The 2025 Forbes 400 List

Four of the ten youngest members of this year's ranking made the list for the first time, including the youngest of all.

time to read

1 mins

October 2025 ENGLISH

Forbes Middle East - English

Forbes Middle East - English

Building Mental Health Systems

The GCC is building a modern mental health system-expanding access, embracing digital tools, and breaking stigma step by step.

time to read

2 mins

October 2025 ENGLISH

Forbes Middle East - English

Forbes Middle East - English

A LEGACY OF TRUST

Bassam Chahine, CEO of SMC Healthcare, has been with the Saudi firm since its founding over 25 years ago. He became CEO in 2024, led its IPO this year, and is now steering the group's next chapter with plans to open three hospitals by 2030.

time to read

6 mins

October 2025 ENGLISH

Listen

Translate

Share

-
+

Change font size